Haleon HLN
NYSE HLN
$10.00 +0.13 (+1.32%)
At close: Aug 21, 2026 · 4:00 PM EDT

Haleon (HLN) EBT Growth (1y) (2022 - 2023)

Haleon (HLN) EBT Growth (1y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -324.14%
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -5.04%
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -1.93%
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -8.74%
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 70.52%
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 1.69%
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 124.00%
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn -101.79%

Historic Data

Download Data
DateValue
Dec 31, 2023 13.37%
Dec 31, 2022 -4.87%